GIS vs NPCE · P/E 8.2, rev $4.61B vs rev $22.8M
General Mills Inc (GIS) versus Neuropace Inc (NPCE) — a side-by-side from cached financials, not a winner call.
General Mills Inc (GIS) is a packaged foods company listed on NYSE.
Neuropace Inc (NPCE) is a medical devices company listed on US.
Latest reported GIS revenue for 2026-05-31 was $4.61B. Net income was -$2.01B. Revenue was up 1.2% from 2025-05-25 to 2026-05-31. GIS currently screens at market cap $17.80B and trailing P/E 8.2.
Latest reported NPCE revenue for 2026-06-30 was $22.8M. Net income was -$6.2M. Revenue was up 3.4% from 2026-03-31 to 2026-06-30. NPCE currently screens at market cap $312.2M.
GIS currently screens at market cap $17.80B and trailing P/E 8.2. NPCE currently screens at market cap $312.2M.
Not investment advice. Open the GIS and NPCE stock pages for the full models.
Not investment advice.